Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients.

MLA

Liu Yang, et al. “Hexokinase 2 Discerns a Novel Circulating Tumor Cell Population Associated with Poor Prognosis in Lung Cancer Patients.” Proceedings of the National Academy of Sciences of the United States of America, vol. 118, no. 11, Mar. 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1073/pnas.2012228118.

APA

Liu Yang, Xiaowei Yan, Jie Chen, Qiong Zhan, Yingqi Hua, Shili Xu, Ziming Li, Zhuo Wang, Yu Dong, Dongqing Zuo, Min Xue, Yin Tang, Herschman, H. R., Shun Lu, Qihui Shi, & Wei Wei. (2021). Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America, 118(11), 1–11. https://doi.org/10.1073/pnas.2012228118

Chicago

Liu Yang, Xiaowei Yan, Jie Chen, Qiong Zhan, Yingqi Hua, Shili Xu, Ziming Li, et al. 2021. “Hexokinase 2 Discerns a Novel Circulating Tumor Cell Population Associated with Poor Prognosis in Lung Cancer Patients.” Proceedings of the National Academy of Sciences of the United States of America 118 (11): 1–11. doi:10.1073/pnas.2012228118.